Rhenman & Partners Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-314,157
| Closed | -$534K | – | 92 |
|
|
2023
Q1 | $534K | Sell |
314,157
-505,843
| -62% | -$860K | 0.06% | 87 |
|
|
2022
Q4 | $2.57M | Hold |
820,000
| – | – | 0.27% | 77 |
|
|
2022
Q3 | $3.6M | Buy |
820,000
+120,000
| +17% | +$527K | 0.38% | 71 |
|
|
2022
Q2 | $2.9M | Sell |
700,000
-61,429
| -8% | -$254K | 0.33% | 67 |
|
|
2022
Q1 | $4.42M | Sell |
761,429
-3,571
| -0.5% | -$20.7K | 0.44% | 66 |
|
|
2021
Q4 | $5.98M | Hold |
765,000
| – | – | 0.4% | 64 |
|
|
2021
Q3 | $6.89M | Hold |
765,000
| – | – | 0.48% | 64 |
|
|
2021
Q2 | $9.16M | Hold |
765,000
| – | – | 0.62% | 58 |
|
|
2021
Q1 | $9.59M | Sell |
765,000
-56,888
| -7% | -$713K | 0.67% | 49 |
|
|
2020
Q4 | $12.8M | Buy |
821,888
+146,888
| +22% | +$2.29M | 1.05% | 40 |
|
|
2020
Q3 | $6.38M | Hold |
675,000
| – | – | 0.57% | 57 |
|
|
2020
Q2 | $6.05M | Sell |
675,000
-25,000
| -4% | -$224K | 0.65% | 54 |
|
|
2020
Q1 | $4.46M | Hold |
700,000
| – | – | 0.62% | 55 |
|
|
2019
Q4 | $5.86M | Sell |
700,000
-34,811
| -5% | -$291K | 0.64% | 60 |
|
|
2019
Q3 | $6.65M | Sell |
734,811
-59,146
| -7% | -$535K | 0.83% | 46 |
|
|
2019
Q2 | $8.55M | Sell |
793,957
-50,000
| -6% | -$539K | 0.94% | 45 |
|
|
2019
Q1 | $8.05M | Sell |
843,957
-260,000
| -24% | -$2.48M | 0.94% | 49 |
|
|
2018
Q4 | $12.7M | Sell |
1,103,957
-93,400
| -8% | -$1.07M | 1.45% | 35 |
|
|
2018
Q3 | $20.3M | Buy |
1,197,357
+145,424
| +14% | +$2.46M | 2.03% | 16 |
|
|
2018
Q2 | $14.9M | Buy |
1,051,933
+796,140
| +311% | +$11.3M | 1.53% | 29 |
|
|
2018
Q1 | $4.86M | Hold |
255,793
| – | – | 0.6% | 57 |
|
|
2017
Q4 | $4.2M | Buy |
+255,793
| New | +$4.2M | 0.57% | 62 |
|